2023 annual financial data
TG Therapeutics 2023 Operating margin
Direct answer
Operating margin was 8.83%.
Operating income was 20,633,000 USD and net income was 12,672,000 USD.
Operating cash flow was -31,413,000 USD.
Get free TG Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 233,662,000 USD
- Operating income
- 20,633,000 USD
- Net income
- 12,672,000 USD
- Operating cash flow
- -31,413,000 USD